Xiaowei William Su MD PhD

Neurology•Hershey, PA

Neuromuscular Medicine

Assistant Professor of Neurology

Join to View Full Profile

30 Hope DrSte 1300Hershey, PA 17033
Phone+1 717-531-3838
Fax+1 717-531-0814

Education & Training

Penn State Milton S Hershey Medical CenterFellowship, Neuromuscular Medicine (Neurology), 2020 - 2021
UPMC Medical Education (Pittsburgh)Residency, Neurology, 2016 - 2020
Pennsylvania State University College of MedicineClass of 2016, M.D.
Penn State UniversityPh.D., Molecular Medicine, 2011 - 2014
Yale UniversityB.S., Biology, Summa cum laude, Phi Beta Kappa, 2008

Certifications & Licensure

PA State Medical License 2020 - 2026
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine
American Association of Neuromuscular & Electrodiagnostic MedicineAmerican Board of Electrodiagnostic Medicine Certification
Penn State Clinical and Translational Science InstituteNIH TL1 Translational Science Certification

Awards, Honors, & Recognition

Neurology Residency Teacher of the Year Award Penn State Department of Neurology, 2022, 2024
Resident Grand Rounds Award UPMC Department of Neurology, 2020
Judith S. Bond M.D., Ph.D. Award Penn State College of Medicine, 2015
Alumni Association Dissertation Award Pennsylvania State University, 2014
Join now to see all

Clinical Trials

HEALEY ALS Platform Trial - Master Protocol Start of enrollment: 2020 Jul 14
Active, not recruiting
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen C CNM-Au8 Start of enrollment: 2020 Jul 30
Completed
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen A Zilucoplan Start of enrollment: 2020 Jul 29
Completed
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen B Verdiperstat Start of enrollment: 2020 Jul 28
Completed
Phase 2, Phase 3
HEALEY ALS Platform Trial - Regimen D Pridopidine Start of enrollment: 2020 Dec 18
Completed
Phase 2, Phase 3
Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2020 Oct 29
COMPLETED
PHASE3
A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2021 Aug 16
TERMINATED
PHASE3
Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS Start of enrollment: 2022 Jan 11
TERMINATED
PHASE3
HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose Start of enrollment: 2022 Feb 21
COMPLETED
PHASE2, PHASE3
Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2022 Apr 13
TERMINATED
PHASE2
HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262 Start of enrollment: 2023 Mar 23
COMPLETED
PHASE2, PHASE3
Two Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01 and CNMAu8.EAP02 for ALS
AVAILABLE
HEALEY ALS Platform Trial - Regimen G DNL343 Start of enrollment: 2023 May 24
COMPLETED
PHASE2, PHASE3
Intermediate Expanded Access Protocol CNMAu8.EAP04
AVAILABLE
Join now to see all

Publications & Presentations

PubMed

Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
, Jeremy M Shefner, Björn Oskarsson, Eric A Macklin, Lori B Chibnik
JAMA. 2025-02-17
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.
, Jinsy Andrews, Sabrina Paganoni, Eric A Macklin, Lori B Chibnik
JAMA Neurology. 2025-02-17
2 citations
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
, James D Berry, Nicholas J Maragakis, Eric A Macklin, Lori B Chibnik
JAMA. 2025-02-17

Committees

Member, NEALS Information and Community Education (NICE) Committee 2021 - Present

Professional Memberships

External Links

NCBI Bibliographyhttps://www.ncbi.nlm.nih.gov/myncbi/1lCCdueh9zbQo/bibliography/public/

Xiaowei William Su MD PhD

Dr. Su is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Committees

Professional Memberships

External Links

Viewing the full profile is available to verified healthcare professionals only.